Upstream Bio Inc
UPB
NASDAQ
Biotechnology
$7.07
USD
+0.16 (+2.32%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $397.81M
Volume 688.2K
Revenue
$3.16M
TTM
— YoY
Gross Margin
100%
TTM
— YoY
Net Income
$-156.50M
TTM
— YoY
Operating Cash Flow
$-136.34M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.9 | 0.7 | 0.7 | 1.0 | 0.8 |
YoY Growth | — | — | +9.0% | +82.7% | -17.5% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.9 | 0.7 | 0.7 | 1.0 | 0.8 |
Selling, General & Administrative | 7.4 | 5.5 | 6.7 | 8.1 | 7.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 45.3 | 38.5 | 46.8 | 44.6 | 43.1 |
Operating Income | -44.3 | -37.8 | -46.2 | -43.6 | -42.4 |
EBITDA | -44.3 | -37.8 | -46.1 | -43.6 | -42.3 |
Other Income / Expense | -0.1 | -0.0 | 0.1 | -0.0 | 0.0 |
Total Other Income / Expense | 4.4 | 4.1 | 3.7 | 3.0 | 2.7 |
Income Before Income Taxes | -40.0 | -33.7 | -42.5 | -40.6 | -39.7 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -40.0 | -33.7 | -42.5 | -40.6 | -39.7 |
Consolidated Net Income / Loss | -40.0 | -33.7 | -42.5 | -40.6 | -39.7 |
Net Income Attributable to Common Shareholders | -40.0 | -33.7 | -42.5 | -40.6 | -39.7 |
Basic EPS | -$0.74 | -$0.63 | -$0.78 | -$0.75 | -$0.73 |
Diluted EPS | -$0.74 | -$0.63 | -$0.78 | -$0.75 | -$0.73 |
Basic Shares Outstanding | 53.8M | 53.9M | 54.1M | 54.3M | 54.6M |
Diluted Shares Outstanding | 53.8M | 53.9M | 54.1M | 54.3M | 54.6M |